SRRK · Scholar Rock Holding Corp

Track SRRK — free

$55.41 -0.26 (-0.47%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$6.75B

121.79M

Up next

Next earnings call

Nov 10, 2026 Est · unconfirmed · in 8 wks

Latest filing: 10-Q

filed Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

Trailing 12 months

Net income (TTM)

−$408.59M

Trailing 12 months

Revenue growth YoY

—

Year over year

Operating margin

—

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

-4.4%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+15.9%

Year over year · more shares

Price change (1Y)

+74.0%

Trailing year

Short interest

14.8%

Latest settlement · 15.4 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Weak Quant / Vol Very High

Market backdrop VIX 15.8 · calm Equity put/call 0.58

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +15%

above

Price vs 50-day avg +3%

above

RSI (14) 51

neutral

MACD trend Negative

52-week position 86%

near high

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Strong

1-month return +4%

trailing

6-month return +24%

trailing

YTD return +26%

this year

Relative strength +6%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $54 › 200d $48 — 50d above 200d

Institutional flow Accumulating

+10% holders QoQ · +56 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

14.79% of float · ▼ -1.2% MoM · 15.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

308 holders — near 3-yr high, broad support

Squeeze score 73

high risk · 0–100

Fundamentals

Weak

EPS growth −33%

Y/Y

Free cash flow $-300.6M

Balance sheet $49.5M

net cash

Quant / Vol

risk profile

Very High

Volatility 60%

annualized · 1-yr

Max drawdown −32%

past year

ATR 4.3%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy

1 · 3 · 3

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+15% Bullish

Price vs 50-day avg

+3% Bullish

RSI (14)

51 Neutral

MACD trend

Negative Bearish

52-week position

86% Bullish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $54 › 200d $48 — 50d above 200d

Institutional flow Accumulating

+10% holders QoQ · +56 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

14.79% of float · ▼ -1.2% MoM · 15.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

308 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $28 Now $55 · 86% Range high $60

vs 200-day avg +15% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
SRRK Scholar Rock Holding Corp this stock	$6.75B	+25.8%	—	—	14.8%
VRTX Vertex Pharmaceuticals Inc / Ma	$130.64B	+13.7%	+46.2%	30.0	1.8%
REGN Regeneron Pharmaceuticals, Inc.	$80.46B	+1.2%	+20.8%	19.4	2.5%
ARGX Argenx SE	$61.22B	+17.1%	—	—	2.0%
MRNA Moderna, Inc.	$57.48B	+388.2%	+4.3%	—	9.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

308

% held: 114.3%
Net QoQ: +5.4M sh
Top holder: FMR LLC

Held Float

View

Held by Funds

Fund positions

306

View

Short & Settlement

Short Interest Falling

Shares short

18.0M

Days to cover: 15.4d
Change: -210.5K sh

View

Short Volume

Short vol %

63%

As of: Sep 11, 2026

Short Total

View

Fails to Deliver

FTD shares

15.6K

Value: $825.1K
As of: Aug 14, 2026

View

Off-Exchange

Off-exchange %

45.4%

Week of: Aug 3, 2026

Off-exch Lit

View

Financials

Revenue (FY)

Net income (FY): $-377.9M
EPS diluted: $-3.29

View

Filings

SEC Filings

Latest

Investor Event Transcript

Filed: Aug 12, 2026
This year: 15

View

Proposed Sales

Value

$1.2M

Shares: 23.4K
Filed: Apr 6, 2026

View

Earnings & Events

Earnings Calls

Last call

Sep 10, 2026

View

Investor Relations

Upcoming events

View

Performance

	5D	20D	120D	MTD	YTD
SRRK	-1.0%	+4.4%	+24.1%	-2.5%	+25.8%
SPY	-1.2%	-1.8%	+17.8%	-0.4%	+12.1%
vs SPY	+0.2%	+6.2%	+6.3%	-2.1%	+13.7%

Key facts CIK 1727196 CUSIP 80706P103 13F (30d) 108 filings 108 filers Visit website Investor relations

SRRK · Scholar Rock Holding Corp

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Technicals

Key metrics

Versus peers

At a glance

Performance